Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer. - Wikidata - awgldk - TriplyDB

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

http://www.wikidata.org/entity/Q33989948

about

Loss of HIF-1α in macrophages attenuates AhR/ARNT-mediated tumorigenesis in a PAH-driven tumor model A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients Impaired lymphatic function accelerates cancer growth.Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer.The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization.Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment.

P2860

Q28828484-FA5EA8E5-931E-4191-A8AE-3F27849594CB Q36955663-4C13D7C4-DC9C-4242-B189-B6CDA19C2CA0 Q37564556-6EB6F616-5F8E-4A7E-8745-D72C6523AAF9 Q38537751-0E6639AF-5953-487D-AB15-546A059B48A2 Q38751278-9BD6656B-0721-4506-8DF2-6719D0926A72 Q42317468-4474D132-9868-4A5C-9A18-AD1A466CF0E5 Q47398937-818BBC1F-A6EE-43E6-A594-2E42CD9C705B

P2860

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

http://www.wikidata.org/entity/Q33989948

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@ast

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@en

type

label

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@ast

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@en

prefLabel

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@ast

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@en

P1433

Q33989948-5EB36814-9C1F-4083-9011-0E7CEC107AC0

P1476

Q33989948-9C776D13-A3F4-4EDC-A05E-68E5D00B6214

P2093

Q33989948-0198FF67-3855-4943-9383-4CDBFE479AA4

Q33989948-0F0DFFA1-7FCB-42FE-A85D-E96790DD2B17

Q33989948-1C5C3318-1297-421C-9375-9B975DE6880D

Q33989948-2CDCCB88-7672-4D40-B3E2-0D986804A2D9

Q33989948-3F3A2A05-BDFD-4987-9A29-B8E3FE739CCF

Q33989948-408E22D4-CC13-43B9-9651-2D9596EFB3D3

Q33989948-4C8B97A3-7F42-4897-A040-09540A13301D

Q33989948-74BD5454-D5FE-4B02-AF02-DBEF03D0E650

Q33989948-781DEC8F-7627-434F-8540-63C967C80A64

Q33989948-B02E8647-D3F3-4B09-A83D-76B273648C0C

P2860

Q33989948-262E8D97-389F-4123-9E94-FCC94D509DCA

Q33989948-278E54D9-645F-41BA-A6E9-328B617561EB

Q33989948-2B166F75-B43B-4B1A-8A3F-B0A942D22EAE

Q33989948-2FC49772-F825-42EF-A80D-0C157DAD9C93

Q33989948-31AED3BC-9A55-411F-BBFA-A83AD3634AB0

Q33989948-3FE82DE4-F422-4277-83F2-918FF9FAA250

Q33989948-4CC72995-4B8C-4425-B10F-A571949C6F24

Q33989948-4FCD8621-D371-4948-9BA6-F32DB257C35F

Q33989948-6AEDDCC1-C9E1-497B-95B0-2D4609050119

Q33989948-737DDDCF-C4D2-44C1-911A-3AE9E0F759F2

P304

Q33989948-6208EC45-4353-4C03-BBB4-F18BF3C27FF7

P31

Q33989948-495BEC7C-0080-4828-9B8B-267001318CB1

P356

Q33989948-448432B4-F0D5-48CC-82C1-5BF9DB440ABF

P433

Q33989948-BC12F201-7F8C-402A-A540-92CCCAB80958

P478

Q33989948-78C6C6FF-99BA-4125-8842-2155FB54F17F

P50

Q33989948-43ABB805-2CCA-4B64-96AE-1255FF8CE745

Q33989948-4AB8A40D-F70C-4024-9F4B-1B052ABB5D60

Q33989948-E6766856-1D58-45DF-867E-8FE93D05EC3D

P577

Q33989948-29477157-7CD4-492D-917B-F8F2A0F5BB15

P5875

Q33989948-F48BC65B-F3E4-4F2C-A8C1-C940E4DAA946

P698

Q33989948-3A98C049-9FB5-419A-9246-F3E1439A0080

P921

Q33989948-45F3932C-38F8-4C03-8B2D-DB495DB2E77D

P932

Q33989948-72811EA7-F174-4175-95A0-015B35D82910

P356

P1433

Cancer Biology and Therapy

P1476

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

Heather J Dalton

http://www.w3.org/2001/XMLSchema#string

Hernan G Vasquez

http://www.w3.org/2001/XMLSchema#string

Jie Huang

http://www.w3.org/2001/XMLSchema#string

Kshipra Gharpure

http://www.w3.org/2001/XMLSchema#string

Nicholas B Jennings

http://www.w3.org/2001/XMLSchema#string

Sunila Pradeep

http://www.w3.org/2001/XMLSchema#string

Takahito Miyake

http://www.w3.org/2001/XMLSchema#string

Vianey Gonzalez-Villasana

http://www.w3.org/2001/XMLSchema#string

P2860

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

Targeted anti-vascular therapies for ovarian cancer: current evidence

Molecular mechanisms and clinical applications of angiogenesis

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

Bisphosphonates: the first 40 years.

Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis.

Endothelial cell migration during angiogenesis.

Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study

Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

P304

1061-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.29184

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Archana S. Nagaraja

Rajesha Rupaimoole

Nicole M Reusser

P577

2014-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262537100

http://www.w3.org/2001/XMLSchema#string

P698

24841852

http://www.w3.org/2001/XMLSchema#string

P921

P932

4119073

http://www.w3.org/2001/XMLSchema#string